Skip to main content
Have a personal or library account? Click to login

References

  1. Joseph P, Leong D, McKee M, Anand SS, Schwalm JD, Teo K, Mente A, Yusuf S. Reducing the Global burden of cardiovascular disease, Part 1: The epidemiology and risk factors. Circ Res. 2017;121(6):677–694. DOI: 10.1161/CIRCRESAHA.117.308903
  2. Warren-Gash, C, Smeeth L, Hayward AC. Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: A systematic review. Lancet Infect Dis. 2009;9:601–610. DOI: 10.1016/S1473-3099(09)70233-6
  3. Clayton TC, Thompson M, Meade TW. Recent respiratory infection and risk of cardiovascular disease: Case-control study through a general practice database. Eur Heart J. 2008;29:96–103. DOI: 10.1093/eurheartj/ehm516
  4. Kwok CS, Aslam S, Kontopantelis E, Myint PK, Zaman MJ, Buchan I, Loke YK, Mamas MA. Influenza, influenza-like symptoms and their association with cardiovascular risks: A systematic review and meta-analysis of observational studies. Int J Clin Pract. 2015;69:928–937. DOI: 10.1111/ijcp.12646
  5. Madjid M, Miller CC, Zarubaev VV, Marinich IG, Kiselev OI, Lobzin YV, Filippov AE, Casscells SW. Influenza epidemics and acute respiratory disease activity are associated with a surge in autopsy-confirmed coronary heart disease death: Results from 8 years of autopsies in 34,892 subjects. Eur Heart J. 2007;28:1205–1210. DOI: 10.1093/eurheartj/ehm035
  6. Kwong JC, Schwartz KL, Campitelli MA, Chung H, Crowcroft NS, Karnauchow T, Katz K, Ko DT, McGeer AJ, McNally D. Acute myocardial infarction after laboratory-confirmed influenza infection. N Engl J Med. 2018;378:345–353. DOI: 10.1056/NEJMoa1702090
  7. Hung IF, Leung AY, Chu DW, Leung D, Cheung T, Chan CK, Lam CL, Liu SH, Chu, CM, Ho PL. Prevention of acute myocardial infarction and stroke among elderly persons by dual pneumococcal and influenza vaccination: A prospective cohort study. Clin Infect Dis. 2010;51:1007–1016. DOI: 10.1086/656587
  8. Nichol KL. Influenza vaccination in the elderly: Impact on hospitalization and mortality. Drugs Aging. 2005;22:495–515. DOI: 10.2165/00002512-200522060-00004
  9. Nichol KL, Margolis KL, Wuorenma J, Von Sternberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med. 1994;331:778–784. DOI: 10.1056/NEJM199409223311206
  10. Nichol KL, Nordin J, Mullooly J, Lask R, Fillbrandt K, Iwane M. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med. 2003;348:1322–1332. DOI: 10.1056/NEJMoa025028
  11. Bridges CB, Fukuda K, Uyeki TM, Cox NJ, Singleton JA; Centers for Disease Control and Prevention; Advisory Committee on Immunization Practices. Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2002;51:1–31.
  12. Udell JA, Zawi R, Bhatt DL, Keshtkar-Jahromi M, Gaughran F, Phrommintikul A, Ciszewski A, Vakili H, Hoffman EB, Farkouh ME. Association between influenza vaccination and cardiovascular outcomes in high-risk patients: A meta-analysis. JAMA. 2013;310:1711–1720. DOI: 10.1001/jama.2013.279206
  13. Clar C, Oseni Z, Flowers N, Keshtkar-Jahromi M, Rees K. Influenza vaccines for preventing cardiovascular disease. Cochrane Database Syst Rev. 2015;2015(5):CD005050. DOI: 10.1002/14651858.CD005050.pub3
  14. LeBras MH, Barry AR. Influenza vaccination for secondary prevention of cardiovascular events: A systematic review. Can J Hosp Pharm. 2017;70:27–34. DOI: 10.4212/cjhp.v70i1.1626
  15. Lamontagne F, Garant MP, Carvalho JC, Lanthier L, Smieja M, Pilon D. Pneumococcal vaccination and risk of myocardial infarction. CMAJ. 2008;179:773–777. DOI: 10.1503/cmaj.070221
  16. Vila-Corcoles A, Ochoa-Gondar O, Rodriguez-Blanco T, Gutierrez-Perez A, Vila-Rovira A, Gomez F, Raga X, de Diego C, Satue E, Salsench E. Clinical effectiveness of pneumococcal vaccination against acute myocardial infarction and stroke in people over 60 years: The CAPAMIS study, one-year follow-up. BMC Public Health. 2012;12:222. DOI: 10.1186/1471-2458-12-222
  17. Rodrigues BS, David C, Costa J, Ferreira JJ, Pinto FJ, Caldeira D. Influenza vaccination in patients with heart failure: A systematic review and meta-analysis of observational studies. Heart. 2020;106:350–357. DOI: 10.1136/heartjnl-2019-315193
  18. Davis BM, Black D. Identifying the challenges to adult influenza vaccination in Latin America. Value Health. 2017;20:PA934. DOI: 10.1016/j.jval.2017.08.2951
  19. Zimmerman RK, Santibanez TA, Fine MJ, Janosky JE, Nowalk MP, Bardella IJ, Raymund M, Wilson SA. Barriers and facilitators of pneumococcal vaccination among the elderly. Vaccine. 2003;21:1510–1517. DOI: 10.1016/S0264-410X(02)00698-9
  20. Centers for Disease Control and Prevention (CDC). Influenza vaccination and self-reported reasons for not receiving influenza vaccination among Medicare beneficiaries aged > or =65 years--United States, 1991–2002. MMWR Morb Mortal Wkly Rep. 2004;53(43):1012–1015.
  21. Centers for Disease Control. Adult immunization: Knowledge, attitudes, and practices—DeKalb and Fulton Counties, Georgia, 1988. JAMA. 1988;260:3253–3255. DOI: 10.1001/jama.1988.03410220023007
  22. Bovier PA, Chamot E, Bouvier Gallacchi M, Loutan L. Importance of patients’ perceptions and general practitioners’ recommendations in understanding missed opportunities for immunisations in Swiss adults. Vaccine. 2001;19:4760–4767. DOI: 10.1016/S0264-410X(01)00223-7
  23. Schmid P, Rauber D, Betsch C, Lidolt G, Denker ML. Barriers of Influenza vaccination intention and behavior—A systematic review of influenza vaccine hesitancy, 2005–2016. PloS ONE. 2017;12: e0170550. DOI: 10.1371/journal.pone.0170550
  24. Burki TK. Vaccine misinformation and social media. Lancet Digit. Health. 2019;1:E258–E259. DOI: 10.1016/S2589-7500(19)30136-0
  25. Hill JA, Agewall S, Baranchuk A, Booz GW, Borer JS, Camici PG, Chen PS, Dominiczak AF, Erol Ç, Grines CL. Medical misinformation: Vet the message! Int J Cardiol. 2019;277:1–2. DOI: 10.1016/j.ijcard.2018.12.071
  26. Chan MS, Jamieson KH, Albarracin D. Prospective associations of regional social media messages with attitudes and actual vaccination: A big data and survey study of the influenza vaccine in the United States. Vaccine. 2020;38:6236–6247. DOI: 10.1016/j.vaccine.2020.07.054
  27. Sosa Liprandi A, Zaidel EJ, Lopez Santi, R, Araujo JJ, Baños González MA, Busso JM, Cabral L, Camilletti J, Erriest J, Flores R. Influenza and Pneumococcal Vaccination in non-infected cardiometabolic patients from the Americas during the COVID-19 pandemic. A sub-analysis of the CorCOVID-LATAM study. Vaccines. 2021;9:123. DOI: 10.3390/vaccines9020123
  28. Organización Panamericana de la Salud. Immunization in the Americas:2024 Summary. PAHO;2025 [cited 2026 August 16th]. Available from: https://iris.paho.org/handle/10665.2/67624
  29. Maguiña-Gorostiaga XA, Bonifacio-Arévalo JG, Sáenz-Vásquez LA, Moreno-Palacios FA, Vela-Ruiz JM, Desposorio-Robles J. Cobertura de vacunación contra neumococo en el adulto mayor en Latinoamérica. Revista Salud Uninorte. 2023;39(3):1060–1077. DOI: 10.14482/sun.39.03.823.357
  30. Wyss F, Lopez-Santi R, Piskorz D, Gonzalez HM, Gutierrez LY, Gupta S, Munera-Echeverri A, Santi PL, Piskorz G, Ullauri V, Gomez JE, del Sueldo M, Almonte C, Mendez M, Valdez O, Ponte-Negretti CI, Rivera MAM, Rivera IR, Barragan AP, Villar R, Effio J, Pineda JAR, Berrospi P, Barrientos AI, Silvera N, Jordan E, Lopez SAX, Quezada D, Arguello A, Perez G, Baranchuk A, On behalf of the CorVacc study investigators. immunization and cardiovascular disease in Latin America. The CorVacc Study: Results. Global Heart. 2025;20(1):108. DOI: 10.5334/gh.1496
  31. Wyss F, Lopez-Santi R, Piskorz D, Gupta S, Munera-Echeverri A, Lopez-Santi P, Piskorz G, Ulluauri V, Gomez JE, Sueldo MD, Almonte C, Mendez M, Valdez O, Ponte-Negreti CI, Romero-Rivera I, Puente-Barragan A, Villar R, Effio J, Pichel D, Berrospi P, Barrientos AI, Silvera N, Jordan E, Dones W, Quezada D, Arguello A, Perez G, Baranchuk A. Immunization and cardiovascular disease in Latin America. The CorVacc study: Rationale and design. Arch Cardiol Mex. 2025;95(3):144–152. DOI: 10.24875/ACM.24000239
  32. Kwong JC, Schwartz KL, Campitelli MA, Chung H, Crowcroft NS, Karnauchow T, Katz K, Ko DT, McGeer AJ, McNally D, Richardson DC, Rosella LC, Simor A, Smieja M, Zahariadis G, Gubbay JB. Acute myocardial infarction after laboratory-confirmed influenza infection. N Engl J Med. 2018;378(4):345–353. DOI: 10.1056/NEJMoa1702090
  33. Chow EJ, Rolfes MA, O’Halloran A, Anderson EJ, Bennett NM, Billing L, Chai S, Dufort E, Herlihy R, Kim S, Lynfield R, McMullen C, Monroe ML, Schaffner W, Spencer M, Talbot HK, Thomas A, Yousey-Hindes K, Reed C, Garg S. Acute Cardiovascular events associated with influenza in hospitalized adults: A cross-sectional study. Ann Intern Med. 2020;173(8):605–613. DOI: 10.7326/M20-1509
  34. Behrouzi B, Bhatt DL, Cannon CP, Vardeny O, Lee DS, Solomon SD, Udell JA. Association of influenza vaccination with cardiovascular risk: A meta-analysis. JAMA Netw Open. 2022;5(4):e228873. DOI: 10.1001/jamanetworkopen.2022.8873
  35. Liprandi ÁS, Liprandi MIS, Zaidel EJ, Aisenberg GM, Baranchuk A, Barbosa ECD, Sánchez GB, Alexander B, Zanetti FTL, Santi RL, Múnera-Echeverri AG, Perel P, Piskorz D, Ruiz-Mori CE, Saucedo J, Valdez O, Juanatey JRG, Piñeiro DJ, Pinto FJ, Quintana FSW. Influenza Vaccination for the prevention of cardiovascular disease in the Americas: Consensus document of the Inter-American Society of Cardiology and the Word Heart Federation. Glob Heart. 2021;16(1):55. DOI: 10.5334/gh.1069
  36. Diao WQ, Shen N, Yu PX, Liu BB, He B. Efficacy of 23-valent pneumococcal polysaccharide vaccine in preventing community-acquired pneumonia among immunocompetent adults: A systematic review and meta-analysis of randomized trials. Vaccine. 2016;34(13):1496–1503. DOI: 10.1016/j.vaccine.2016.02.023
  37. Kobayashi M, Leidner AJ, Gierke R, Xing W, Accorsi E, Moro P, Kamboj M, Kuchel GA, Schechter R, Loehr J, Cohen AL. Expanded Recommendations for Use of Pneumococcal Conjugate Vaccines Among Adults Aged ≥50 Years: Recommendations of the Advisory Committee on Immunization Practices – United States, 2024. MMWR Morb Mortal Wkly Rep. 2025;74(1):1–8. DOI: 10.15585/mmwr.mm7401a1
  38. Kawai K, Muhere CF, Lemos EV, Francis JM. Viral infections and risk of cardiovascular disease: systematic review and meta-analysis. J Am Heart Assoc. 2025;14(21):e042670. DOI: 10.1161/JAHA.125.042670
  39. Aggarwal G, Cheruiyot I, Aggarwal S, Wong J, Lippi G, Lavie CJ, Henry BM, Sanchis-Gomar F. Association of cardiovascular disease with coronavirus disease 2019 (COVID-19) severity: A meta-analysis. Curr Probl Cardiol. 2020;45(8):100617. DOI: 10.1016/j.cpcardiol.2020.100617
  40. Pellicori P, Doolub G, Wong CM, Lee KS, Mangion K, Ahmad M, Berry C, Squire I, Lambiase PD, Lyon A, McConnachie A, Taylor RS, Cleland JG. COVID-19 and its cardiovascular effects: a systematic review of prevalence studies. Cochrane Database Syst Rev. 2021;3(3):CD013879. DOI: 10.1002/14651858.CD013879
  41. Writing Committee Members; Virani SS, Newby LK, Arnold SV, Bittner V, Brewer LC, Demeter SH, Dixon DL, Fearon WF, Hess B, Johnson HM, Kazi DS, Kolte D, Kumbhani DJ, LoFaso J, Mahtta D, Mark DB, Minissian M, Navar AM, Patel AR, Piano MR, Rodriguez F, Talbot AW, Taqueti VR, Thomas RJ, van Diepen S, Wiggins B, Williams MS. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the management of patients with chronic coronary disease: A report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2023;82(9):833–955. DOI: 10.1016/j.jacc.2023.04.003. Erratum in: J Am Coll Cardiol. 2023;82(18):1808. DOI: https://doi.org/10.1016/j.jacc.2023.09.794. Erratum in: J Am Coll Cardiol. 2024;83(17):1716. DOI: https://doi.org/10.1016/j.jacc.2024.03.399
  42. Heidenreich PA, Bhatt A, Nazir NT, Schaffner W, Vardeny O. Adult immunizations as part of cardiovascular care:2026 ACC Concise Clinical Guidance: A report of the American College of Cardiology solution set oversight committee. J Am Coll Cardiol. 2026; S0735-1097(26):07068-3. DOI: 10.1016/j.jacc.2026.07.004
DOI: https://doi.org/10.5334/gh.1600 | Journal eISSN: 2211-8179 | Journal ISSN: 2211-8160
Language: English
Page range: 81 - 81
Submitted on: Feb 1, 2026
Accepted on: Oct 19, 2026
Published on: Nov 12, 2026
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services

© 2026 Fernando Wyss, Daniel Piskorz, Ricardo Lopez-Santi, Lucelli Yañez Gutiérrez, Horacio Márquez-Gonzales, Fabio Enrique Parada, Vladimir Ullauri, Ana Munera Echeverri, Juan Esteban Gómez, Osiris Valdez, Máxima Méndez, Claudia Almonte, Carlos Ponte-Negretti, María Alayde Mendoça Rivera, Iván Romero Rivera, Raúl Villar, Jorge Alberto Rivera, Dulman Pineda de Paz, Ana Isabel Barrientos, Edmundo Jordan, Gonzalo Piskorz, Pilar Lopez-Santi, CorVacc study investigators. Cardiovascular Prevention Council (SIAC-PREVENT) of the Inter-American Society of Cardiology (SIAC), published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.